These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11118039

  • 1. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
    Sumitomo M, Shen R, Goldberg JS, Dai J, Navarro D, Nanus DM.
    Cancer Res; 2000 Dec 01; 60(23):6590-6. PubMed ID: 11118039
    [Abstract] [Full Text] [Related]

  • 2. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
    Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M, Nanus DM.
    Cancer Res; 2001 Apr 15; 61(8):3294-8. PubMed ID: 11309283
    [Abstract] [Full Text] [Related]

  • 3. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
    Gschwend JE, Fair WR, Powell CT.
    Mol Pharmacol; 2000 Jun 15; 57(6):1224-34. PubMed ID: 10825394
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N, Korkmaz CG, Saatcioglu F.
    Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
    Sumitomo M, Asano T, Asakuma J, Asano T, Nanus DM, Hayakawa M.
    Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):260-6. PubMed ID: 14734478
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
    Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT, Nanus DM.
    Clin Cancer Res; 2001 May 01; 7(5):1370-7. PubMed ID: 11350908
    [Abstract] [Full Text] [Related]

  • 9. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
    Sumitomo M, Shen R, Walburg M, Dai J, Geng Y, Navarro D, Boileau G, Papandreou CN, Giancotti FG, Knudsen B, Nanus DM.
    J Clin Invest; 2000 Dec 01; 106(11):1399-407. PubMed ID: 11104793
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
    Zheng R, Iwase A, Shen R, Goodman OB, Sugimoto N, Takuwa Y, Lerner DJ, Nanus DM.
    Oncogene; 2006 Sep 28; 25(44):5942-52. PubMed ID: 16652149
    [Abstract] [Full Text] [Related]

  • 12. The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells.
    Henttu P, Vihko P.
    Biochem Biophys Res Commun; 1998 Mar 06; 244(1):167-71. PubMed ID: 9514905
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts.
    Heit I, Wieser RJ, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F, Dietrich C.
    Oncogene; 2001 Aug 23; 20(37):5143-54. PubMed ID: 11526503
    [Abstract] [Full Text] [Related]

  • 16. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
    Gavrielides MV, Gonzalez-Guerrico AM, Riobo NA, Kazanietz MG.
    Cancer Res; 2006 Dec 15; 66(24):11792-801. PubMed ID: 17178875
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R, Kiguchi Y, Shimizu T, Suzuki T, Hamada H, Takeda K.
    Anticancer Res; 2002 Dec 15; 22(2A):713-9. PubMed ID: 12014641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
    Mandil R, Ashkenazi E, Blass M, Kronfeld I, Kazimirsky G, Rosenthal G, Umansky F, Lorenzo PS, Blumberg PM, Brodie C.
    Cancer Res; 2001 Jun 01; 61(11):4612-9. PubMed ID: 11389098
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
    Hrzenjak M, Shain SA.
    Recept Signal Transduct; 1997 Jun 01; 7(4):207-19. PubMed ID: 9633822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.